Adalimumab Maintains Remission for Up to 4 Years in Patients With Ulcerative Colitis

被引：0
|
作者：
Colombel, Jean-Frederic
Sandborn, William
Ghosh, Subrata
Wolf, Douglas C.
Panaccione, Remo
Feagan, Brian G.
Reinisch, Walter
Robinson, Anne
Lazar, Andreas
Kron, Martina
Huang, Bidan
Thakkar, Roopal
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1221
引用
收藏
页码：S589 / S590
页数：2
相关论文
共 50 条
  • [41] Assessment of Lactose Intolerance in Ulcerative Colitis Patients on Remission
    Ahishali, E.
    Akkus, E. E.
    Dolapcioglu, C.
    Sayiner, M.
    Arslan, T.
    Yilmaz, R.
    Kural, A.
    Dabak, R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S351 - S351
  • [42] Crypts in Asymmetric Branching in Patients With Ulcerative Colitis in Remission
    Rubio, Carlos A.
    Vieth, Michael
    Lang-Schwarz, Corinna
    [J]. ANTICANCER RESEARCH, 2022, 42 (09) : 4493 - 4497
  • [43] Predictors of Deep Remission in Patients With Inactive Ulcerative Colitis
    Rosenberg, Laura N.
    Lawlor, Garrett
    Gifford, Anne E.
    Falchuk, Kenneth R.
    Wolf, Jacqueline L.
    Cheifetz, Adam S.
    Moss, Alan C.
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S660 - S661
  • [44] Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis
    Colombel, Jean-Frederic
    Osterman, Mark T.
    Thorpe, Andrew J.
    Salese, Leonardo
    Nduaka, Chudy I.
    Zhang, Haiying
    Lawendy, Nervin
    Friedman, Gary S.
    Quirk, Daniel
    Su, Chinyu
    Reinisch, Walter
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (01) : 116 - +
  • [45] Is infliximab effective for induction of remission in patients with ulcerative colitis?
    Lichtenstein, GR
    [J]. INFLAMMATORY BOWEL DISEASES, 2001, 7 (02) : 89 - 93
  • [46] Adalimumab: A Review of Its Use in the Treatment of Patients with Ulcerative Colitis
    Burness, Celeste B.
    Keating, Gillian M.
    [J]. BIODRUGS, 2013, 27 (03) : 247 - 262
  • [47] Adalimumab: A Review of Its Use in the Treatment of Patients with Ulcerative Colitis
    Celeste B. Burness
    Gillian M. Keating
    [J]. BioDrugs, 2013, 27 : 247 - 262
  • [48] Safety of Adalimumab in Global Clinical Trials of Ulcerative Colitis Patients
    Colombel, Jean-Frederic
    Ghosh, Subrata
    Sandborn, William
    Van Assche, Gert A.
    Reinisch, Walter
    Lazar, Andreas
    Eichner, Samantha
    Huang, Bidan
    Robinson, Anne
    Thakkar, Roopal
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S231 - S232
  • [49] Comparative effectiveness and safety of infliximab and adalimumab in patients with ulcerative colitis
    Singh, S.
    Heien, H. C.
    Sangaralingham, L. R.
    Schilz, S. R.
    Kappelman, M. D.
    Shah, N. D.
    Loftus, E. V.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (09) : 994 - 1003
  • [50] Real-world effectiveness of adalimumab in patients with ulcerative colitis
    Armuzzi, A.
    Taxonera, C.
    Panes, J.
    Lakatos, P.
    Fisseha, N.
    Pappalardo, B.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S280 - S282
12345